• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Advances in biomimetic regeneration of elastic matrix structures.弹性基质结构仿生再生的研究进展。
Drug Deliv Transl Res. 2012 Oct;2(5):323-50. doi: 10.1007/s13346-012-0070-6.
2
Tissue engineering and regenerative strategies to replicate biocomplexity of vascular elastic matrix assembly.组织工程和再生策略,以复制血管弹性基质组装的生物复杂性。
Tissue Eng Part B Rev. 2012 Jun;18(3):203-17. doi: 10.1089/ten.TEB.2011.0521. Epub 2012 Mar 2.
3
Basic Components of Connective Tissues and Extracellular Matrix: Fibronectin, Fibrinogen, Laminin, Elastin, Fibrillins, Fibulins, Matrilins, Tenascins and Thrombospondins.结缔组织和细胞外基质的基本成分:纤连蛋白、纤维蛋白原、层粘连蛋白、弹性蛋白、原纤维蛋白、纤连蛋白、基质金属蛋白酶诱导因子、腱蛋白和血栓调节蛋白。
Adv Exp Med Biol. 2021;1348:105-126. doi: 10.1007/978-3-030-80614-9_4.
4
Basic components of connective tissues and extracellular matrix: elastin, fibrillin, fibulins, fibrinogen, fibronectin, laminin, tenascins and thrombospondins.结缔组织和细胞外基质的基本成分:弹性蛋白、原纤维蛋白、纤连蛋白、纤维蛋白原、纤维连接蛋白、层粘连蛋白、腱生蛋白和血栓调节蛋白。
Adv Exp Med Biol. 2014;802:31-47. doi: 10.1007/978-94-007-7893-1_3.
5
Gene Silencing for Elastic Matrix Regenerative Repair.用于弹性基质再生修复的基因沉默
Tissue Eng Part A. 2022 Mar;28(5-6):239-253. doi: 10.1089/ten.TEA.2020.0221.
6
Induced elastic matrix deposition within three-dimensional collagen scaffolds.在三维胶原支架内诱导弹性基质沉积。
Tissue Eng Part A. 2011 Nov;17(21-22):2879-89. doi: 10.1089/ten.TEA.2010.0749. Epub 2011 Aug 29.
7
Impact of pre-existing elastic matrix on TGFβ1 and HA oligomer-induced regenerative elastin repair by rat aortic smooth muscle cells.原弹性基质对 TGFβ1 和 HA 低聚物诱导的大鼠主动脉平滑肌细胞再生弹性蛋白修复的影响。
J Tissue Eng Regen Med. 2011 Feb;5(2):85-96. doi: 10.1002/term.286.
8
Role of elastic fiber degradation in disease pathogenesis.弹性纤维降解在疾病发病机制中的作用。
Biochim Biophys Acta Mol Basis Dis. 2023 Jun;1869(5):166706. doi: 10.1016/j.bbadis.2023.166706. Epub 2023 Mar 29.
9
Spatiotemporal changes in mechanical matrisome components of the human ovary from prepuberty to menopause.人类卵巢从青春期前到绝经期机械基质组件的时空变化。
Hum Reprod. 2020 Jun 1;35(6):1391-1410. doi: 10.1093/humrep/deaa100.
10
Copper nanoparticle cues for biomimetic cellular assembly of crosslinked elastin fibers.用于交联弹性蛋白纤维仿生细胞组装的铜纳米颗粒线索
Acta Biomater. 2009 Feb;5(2):541-53. doi: 10.1016/j.actbio.2008.09.004. Epub 2008 Sep 21.

引用本文的文献

1
Electrically conductive biopolymer-based hydrogels and fibrous materials fabricated using 3D printing and electrospinning for cardiac tissue engineering.使用3D打印和静电纺丝技术制备的用于心脏组织工程的基于导电生物聚合物的水凝胶和纤维材料。
Bioact Mater. 2025 Jun 9;51:650-719. doi: 10.1016/j.bioactmat.2025.05.014. eCollection 2025 Sep.
2
Decellularization of the human urethra for tissue engineering applications.人尿道脱细胞化用于组织工程应用。
Exp Biol Med (Maywood). 2023 Jun;248(12):1034-1042. doi: 10.1177/15353702231162092. Epub 2023 Apr 18.
3
Stem Cell Based Approaches to Modulate the Matrix Milieu in Vascular Disorders.基于干细胞的方法调节血管疾病中的基质环境
Front Cardiovasc Med. 2022 Jun 15;9:879977. doi: 10.3389/fcvm.2022.879977. eCollection 2022.
4
Stem cell derived extracellular vesicles for vascular elastic matrix regenerative repair.干细胞衍生的细胞外囊泡用于血管弹性基质的再生修复。
Acta Biomater. 2020 Sep 1;113:267-278. doi: 10.1016/j.actbio.2020.07.002. Epub 2020 Jul 6.
5
Assessing the targeting and fate of cathepsin k antibody-modified nanoparticles in a rat abdominal aortic aneurysm model.评估组织蛋白酶 K 抗体修饰的纳米颗粒在大鼠腹主动脉瘤模型中的靶向性和命运。
Acta Biomater. 2020 Aug;112:225-233. doi: 10.1016/j.actbio.2020.05.037. Epub 2020 Jun 3.
6
Elastin-derived scaffolding associated or not with bone morphogenetic protein (BMP) or hydroxyapatite (HA) in the repair process of metaphyseal bone defects.在干骺端骨缺损修复过程中,弹性蛋白衍生支架与骨形态发生蛋白(BMP)或羟基磷灰石(HA)相关或不相关。
PLoS One. 2020 Apr 20;15(4):e0231112. doi: 10.1371/journal.pone.0231112. eCollection 2020.
7
Nanoparticle-based targeted delivery of pentagalloyl glucose reverses elastase-induced abdominal aortic aneurysm and restores aorta to the healthy state in mice.基于纳米颗粒的五没食子酰葡萄糖靶向递送逆转弹性蛋白酶诱导的腹主动脉瘤,并使小鼠的主动脉恢复健康状态。
PLoS One. 2020 Mar 27;15(3):e0227165. doi: 10.1371/journal.pone.0227165. eCollection 2020.
8
Alterations in phenotype and gene expression of adult human aneurysmal smooth muscle cells by exogenous nitric oxide.外源性一氧化氮对成人颅内动脉瘤平滑肌细胞表型和基因表达的影响。
Exp Cell Res. 2019 Nov 1;384(1):111589. doi: 10.1016/j.yexcr.2019.111589. Epub 2019 Aug 29.
9
Comparing the Role of Mechanical Forces in Vascular and Valvular Calcification Progression.比较机械力在血管钙化和瓣膜钙化进展中的作用。
Front Cardiovasc Med. 2019 Jan 10;5:197. doi: 10.3389/fcvm.2018.00197. eCollection 2018.
10
Nanotherapeutics to Modulate the Compromised Micro-Environment for Lung Cancers and Chronic Obstructive Pulmonary Disease.用于调节肺癌和慢性阻塞性肺疾病受损微环境的纳米疗法
Front Pharmacol. 2018 Jul 16;9:759. doi: 10.3389/fphar.2018.00759. eCollection 2018.

本文引用的文献

1
Prolonged retention and in vivo evaluation of cationic nanoparticles loaded with Mitomycin C designed for intravesical chemotherapy of bladder tumours.载丝裂霉素 C 的阳离子纳米粒用于膀胱癌腔内化疗的体内保留时间和评价。
J Microencapsul. 2012;29(6):576-82. doi: 10.3109/02652048.2012.668957. Epub 2012 Apr 3.
2
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation.靶向聚合物治疗纳米粒:设计、开发与临床转化。
Chem Soc Rev. 2012 Apr 7;41(7):2971-3010. doi: 10.1039/c2cs15344k. Epub 2012 Mar 5.
3
MicroRNA-21 blocks abdominal aortic aneurysm development and nicotine-augmented expansion.微小 RNA-21 阻断腹主动脉瘤的发展和烟碱增强的扩张。
Sci Transl Med. 2012 Feb 22;4(122):122ra22. doi: 10.1126/scitranslmed.3003441.
4
Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development.抑制 microRNA-29b 可减少小鼠腹主动脉瘤的发展。
J Clin Invest. 2012 Feb;122(2):497-506. doi: 10.1172/JCI61598. Epub 2012 Jan 24.
5
Doxycycline delivery from PLGA microspheres prepared by a modified solvent removal method.载多西环素 PLGA 微球的制备及溶剂挥发法的改进。
J Microencapsul. 2012;29(4):344-52. doi: 10.3109/02652048.2011.651499. Epub 2012 Jan 23.
6
Tissue engineering and regenerative strategies to replicate biocomplexity of vascular elastic matrix assembly.组织工程和再生策略,以复制血管弹性基质组装的生物复杂性。
Tissue Eng Part B Rev. 2012 Jun;18(3):203-17. doi: 10.1089/ten.TEB.2011.0521. Epub 2012 Mar 2.
7
Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cells.表面电荷对 PLGA 纳米颗粒对 Calu-3 细胞潜在毒性的影响。
Int J Nanomedicine. 2011;6:2591-605. doi: 10.2147/IJN.S24552. Epub 2011 Oct 26.
8
The role of elastin peptides in modulating the immune response in aging and age-related diseases.弹性蛋白肽在调节衰老及与年龄相关疾病中的免疫反应中的作用。
Pathol Biol (Paris). 2012 Feb;60(1):28-33. doi: 10.1016/j.patbio.2011.10.006. Epub 2011 Nov 17.
9
Inhibition of microRNA-29 enhances elastin levels in cells haploinsufficient for elastin and in bioengineered vessels--brief report.miR-29 抑制可增强弹性蛋白单倍不足的细胞和生物工程血管中的弹性蛋白水平——简短报告。
Arterioscler Thromb Vasc Biol. 2012 Mar;32(3):756-9. doi: 10.1161/ATVBAHA.111.238113. Epub 2011 Nov 17.
10
Alignment of human vascular smooth muscle cells on parallel electrospun synthetic elastin fibers.人血管平滑肌细胞在平行电纺合成弹性纤维上的排列。
J Biomed Mater Res A. 2012 Jan;100(1):155-61. doi: 10.1002/jbm.a.33255. Epub 2011 Oct 14.

弹性基质结构仿生再生的研究进展。

Advances in biomimetic regeneration of elastic matrix structures.

机构信息

Department of Biomedical Engineering, The Cleveland Clinic, 9500 Euclid Avenue, ND 20, Cleveland, OH 44195, USA.

出版信息

Drug Deliv Transl Res. 2012 Oct;2(5):323-50. doi: 10.1007/s13346-012-0070-6.

DOI:10.1007/s13346-012-0070-6
PMID:23355960
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3551595/
Abstract

Elastin is a vital component of the extracellular matrix, providing soft connective tissues with the property of elastic recoil following deformation and regulating the cellular response via biomechanical transduction to maintain tissue homeostasis. The limited ability of most adult cells to synthesize elastin precursors and assemble them into mature crosslinked structures has hindered the development of functional tissue-engineered constructs that exhibit the structure and biomechanics of normal native elastic tissues in the body. In diseased tissues, the chronic overexpression of proteolytic enzymes can cause significant matrix degradation, to further limit the accumulation and quality (e.g., fiber formation) of newly deposited elastic matrix. This review provides an overview of the role and importance of elastin and elastic matrix in soft tissues, the challenges to elastic matrix generation in vitro and to regenerative elastic matrix repair in vivo, current biomolecular strategies to enhance elastin deposition and matrix assembly, and the need to concurrently inhibit proteolytic matrix disruption for improving the quantity and quality of elastogenesis. The review further presents biomaterial-based options using scaffolds and nanocarriers for spatio-temporal control over the presentation and release of these biomolecules, to enable biomimetic assembly of clinically relevant native elastic matrix-like superstructures. Finally, this review provides an overview of recent advances and prospects for the application of these strategies to regenerating tissue-type specific elastic matrix structures and superstructures.

摘要

弹性蛋白是细胞外基质的重要组成部分,为柔软的结缔组织提供了变形后弹性回弹的特性,并通过生物力学转导来调节细胞反应,以维持组织内稳态。大多数成年细胞合成弹性蛋白前体并将其组装成成熟交联结构的能力有限,这阻碍了功能性组织工程构建体的发展,这些构建体在体内表现出正常天然弹性组织的结构和生物力学特性。在患病组织中,蛋白酶的慢性过度表达会导致基质的显著降解,进一步限制新沉积的弹性基质的积累和质量(例如纤维形成)。这篇综述概述了弹性蛋白和弹性基质在软组织中的作用和重要性、体外弹性基质生成和体内再生弹性基质修复的挑战、增强弹性蛋白沉积和基质组装的当前生物分子策略,以及需要同时抑制蛋白水解基质破坏以提高弹性生成的数量和质量。该综述进一步介绍了基于生物材料的选项,使用支架和纳米载体来控制这些生物分子的呈现和释放,以实现临床相关的天然弹性基质样超结构的仿生组装。最后,该综述概述了这些策略在再生组织特异性弹性基质结构和超结构方面的最新进展和应用前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f071/3551595/c77134f7be6e/nihms409572f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f071/3551595/a5dafd3a9ad3/nihms409572f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f071/3551595/729a398a8a28/nihms409572f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f071/3551595/bc5fb70b9de4/nihms409572f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f071/3551595/c77134f7be6e/nihms409572f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f071/3551595/a5dafd3a9ad3/nihms409572f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f071/3551595/729a398a8a28/nihms409572f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f071/3551595/bc5fb70b9de4/nihms409572f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f071/3551595/c77134f7be6e/nihms409572f4.jpg